Filter
389
Filtered Results: 389
Text search:
Filariasis
Featured
Recommendations
47
New Publications
117
Language
Document type
No document type
184
Studies & Reports
86
Guidelines
52
Strategic & Response Plan
29
Manuals
18
Videos
5
Training Material
4
Infographics
3
Fact sheets
3
Brochures
1
Dashboards/Maps
1
Situation Updates
1
Resource Platforms
1
Online Courses
1
Countries / Regions
Global
48
India
21
Ethiopia
14
Sierra Leone
11
Africa
11
Nepal
10
Latin America and the Carribbean
10
Uganda
10
Indonesia
10
Liberia
10
Kenya
8
Ghana
8
Malawi
6
Philippines
5
Tanzania
5
Bangladesh
5
Zambia
5
Rwanda
4
Cameroon
4
Burkina Faso
4
Mozambique
4
South–East Asia Region
4
South Sudan
4
Myanmar / Burma
4
Iran
3
Nigeria
3
Saudi Arabia
3
Congo, Democratic Republic of
3
Sudan
3
Yemen
3
Syria
2
Asia
2
Jordan
2
Bolivia
2
Lebanon
2
Djibouti
2
Egypt
2
Botswana
2
Iraq
2
Somalia
2
Pakistan
2
Timor Leste/ East Timor
1
Lesotho
1
Albania
1
Laos
1
Senegal
1
Niger
1
Afghanistan
1
Zimbabwe
1
Morocco
1
Qatar
1
Guinea
1
Haiti
1
Cambodia
1
Venezuela
1
Germany
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Western and Central Europe
1
Paraguay
1
Tunisia
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Papua New Guinea
1
Brazil
1
Sri Lanka
1
Greece
1
Palestine
1
Georgia
1
Mali
1
Angola
1
Libya
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
158
Clinical Guidelines
53
Public Health
36
Key Resources
16
Pharmacy & Technologies
7
Women & Child Health
6
Capacity Building
5
Toolboxes
NTDs
114
Rapid Response
20
Planetary Health
12
Pharmacy
9
Ebola
6
Caregiver
5
NCDs
4
Natural Hazards
3
Disability
3
Global Health Education
3
Mental Health
2
Refugee
2
Cholera
2
COVID-19
2
AMR
2
HIV
1
TB
1
Social Ethics
1
Conflict
1
Zika
1
Polio
1
Lymphatic filariasis (LF) is an avoidable, debilitating, disfiguring disease caused by infection with the filarial parasites Wuchereria bancrofti, Brugia malayi and B. timori. Globally, 51.4 million people are
estimated to be infected. Lymphoedema and hydrocoele are the visible, chronic clinical co...
Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease. Infection occurs when filarial parasites are transmitted to humans through mosquitoes. Infection is usually acquired in childhood causing hidden damage to the lymphatic system.
Lymphatic filariasis, commonly known as elephantiasis, is a neglected tropical disease. Infection occurs when filarial parasites are transmitted to humans through mosquitoes. When a mosquito with infective stage larvae bites a person, the parasites are deposited on the person’s skin from where the...
The content of these guidelines goes beyond the technicalities of medical needs with additional insights into community empowerment, possible access to welfare and economic opportunities and similar issues. If these are adequately explored, the health and quality of life of people affected and their...
Analysis of microfilaria prevalence data from 430 communities
Poster
Stop filariasis now
do the right thing to save the next generation
To eliminate lymphatic filariasis (LF) by 2020, the World Health Organization (WHO) has launched a campaign against the disease. Since the launch in 2000, significant progress has been made to achieve this ambitious goal. In this article we review the progress and status of the LF programme in Afric...
The purpose of this TPP is to communicate the minimum and ideal characteristics desired to meet the need for discriminating low levels of risk for transmission, i.e. targeted prevalence thresholds in the surveyed areas. An in vitro diagnostic test is needed for the detection of analyte(s) specific t...
The Global Programme to Eliminate Lymphatic Filariasis (LF) is using mass drug administration (MDA) of antifilarial medications to treat filarial infections, prevent disease and interrupt transmission. Almost 500 million people receive these medications each year. Clinical trials have recently shown...
In 1997, the Fiftieth World Health Assembly adopted resolution WHA50.29 on the elimination of
lymphatic filariasis as a public health problem. Preliminary guidance from WHO printed in 2011 referred to “verification” as the official process by which the achievements of the Global Programme to El...
In South and Central America, lymphatic filariasis (LF) is caused by Wuchereria bancrofti, which is transmitted by Culex quinquefasciatus, the only vector species in this region. Of the seven countries considered endemic for LF in the Americas in the last decade, Costa Rica, Suriname and Trinidad a...
The Western Pacific Region is the largest and most diverse region in the world, made up of 37 countries and territories in the Pacific, Oceania and parts of Asia, with a population of more than 1.9 billion people stretching over an area from China and Mongolia in the north to New Zealand in the sout...
During the 17 years since Surgical approaches to the urogenital manifestations of lymphatic filariasis was first published, there has been heightened awareness of the physical, economic and emotional burden of the genitourinary manifestations of filariasis. With the impetus to provide better guidanc...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
